Taro Goto

Sociodemographics, Comorbidities, Healthcare Utilization and Work Productivity in Japanese Patients with Adult ADHD

Eiji Kirino, Hideyuki Imagawa, Taro Goto et al. · PLoS ONE · 2015 · 47 citations · Full text

Medicine, Health Sciences, Psychiatry +17

Efficacy and Safety of Atomoxetine Hydrochloride in Asian Adults With ADHD

Taro Goto, Yuko Hirata, Yasushi Takita et al. · Journal of Attention Disorders · 2013 · 39 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Executive Function in Adults With Attention-Deficit/Hyperactivity Disorder During Treatment With Atomoxetine in a Randomized, Placebo-Controlled, Withdrawal Study

Lenard A. Adler, Yoko Tanaka, David W. Williams et al. · Journal of Clinical Psychopharmacology · 2014 · 28 citations

Medicine, Pharmacotherapy, Psychiatry +17

CYP2D6 predicted metabolizer status and safety in adult patients with attention‐deficit hyperactivity disorder participating in a large placebo‐controlled atomoxetine maintenance of response clinical trial

Bonnie A. Fijal, Yingying Guo, Si G. Li et al. · The Journal of Clinical Pharmacology · 2015 · 24 citations

Medicine, Pharmacology, Psychiatry +17

An open‐label, dose‐titration tolerability study of atomoxetine hydrochloride in Japanese adults with attention‐deficit/hyperactivity disorder

Michihiro Takahashi, Yasushi Takita, Taro Goto et al. · Psychiatry and Clinical Neurosciences · 2011 · 20 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13